| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Scientific Officer
1 company
Dunne Michael W. is a Director at Iterum Therapeutics plc. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $7K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 30, 2018 | ITRM Iterum Therapeutics Plc | Chief Scientific Officer | Buy | 2,000 | $13.00 | $26,000.00 | +1.4% |